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ABSTRACT 
Background: The identification of the molecular basis of disorders of keratinization has 
significantly advanced our understanding of skin biology, revealing new information on key 
structures in the skin, such as the intermediate filaments, desmosomes and gap junctions. Among 
these disorders, there is an extraordinarily heterogeneous group known as palmoplantar 
keratodermas (PPK), for which only a few molecular defects have been described. A particular 
form of PPK, known as punctate PPK, has been described in a few large autosomal dominant 
pedigrees, but its genetic basis has yet to be identified. 
Purpose: Identification of the gene for punctate PPK. 
Methods: Clinical examination and linkage analysis in three families with punctate PPK. 
Results: A genomewide scan was performed on an extended autosomal dominant pedigree and 
linkage to chromosome 15q22-q24 was identified. With the addition of two new families with 
the same phenotype, we confirmed the mapping of the locus for punctate PPK to a 9.98-cM 
interval, flanked by markers D15S534 and D15S818 (maximum two-point LOD score of 4.93 at 
θ=0 for marker D15S988). 
Conclusions: We report the clinical and genetic findings in three pedigrees with the punctate 
form of PPK.  We have mapped a genetic locus for this phenotype to chromosome 15q22-q24, 
anticipating the identification of a new gene involved in skin integrity. 
 
Key words: palmoplantar keratoderma, linkage analysis, chromosome 15. 
 
Abbreviations: ITGA11, integrin alpha 11 gene; LOXL1, lysyl oxidase-like 1 gene; OMIM, 
Online Mendelian Inheritance in Man; PPK, palmoplantar keratoderma. 
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INTRODUCTION 
Palmoplantar keratodermas (PPKs) are a family of diseases characterized by hyperkeratosis of 
the palms and soles. Defects in different components of the desmosomes and the keratin 
filaments have been described, but many forms of the disease still have an unknown molecular 
basis. PPK is clinically and genetically heterogeneous, and can be classified into three main 
categories according to the affected area of the palms and soles: diffuse, focal and punctate [1]. It 
can be inherited as an autosomal recessive, autosomal dominant, mitochondrial and, possibly, X-
linked recessive trait. The autosomal dominant forms of PPK represent one of the most common 
defects of keratinization [2], however, their molecular basis remains largely unknown. The 
clinical picture of PPKs can range from strict involvement of the palms and soles, accompanied 
by epidermolysis (epidermolytic and non-epidermolytic forms), to a wider ectodermal defect 
(palmoplantar ectodermal dysplasias), or associated with cardiomyopathy [3-5], deafness [6, 7] 
or different forms of cancer [1]. Examples of the latter are tylosis (focal non-epidermolytic PPK) 
with esophageal cancer (TOC) [8], Huriez syndrome (diffuse PPK associated with squamous cell 
carcinoma) [9] and punctate PPK, occasionally associated with different types of malignancies 
[2, 10]. Association of epidermolytic diffuse PPK with breast and ovarian cancer has also been 
described in a large pedigree [11]. Mutational analysis, however, determined that the PPK 
phenotype was caused by a mutation in the KRT9 gene, while the cancer phenotype was the 
result of a mutation in the BRCA1 gene [12, 13]. 
 As is the case for many other human inherited skin diseases, PPKs exhibit extensive 
genetic heterogeneity. So far, mutations in more than fifteen genes have been identified in 
different forms of PPK [14, 15]. These genes code for components of the intermediate filaments, 
such as keratin 1 [16], keratin 6a [17], keratin 6b [18], keratin 9 [19, 20], keratin 16 [21] and 
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keratin 17 [21, 22]; the desmosome, such as desmoglein 1 [16, 23], desmoplakin [4, 24, 25] and 
plakoglobin [3, 26]; gap junction channels, such as connexin 26 [27], connexin 30 [28, 29] and 
connexin 31 [30]; loricrin, a major component of the cornified cell envelope [31]; and a diverse 
group comprising the proteolytic protein cathepsin C [32], SLURP-1 [33] and a mitochondrial 
transfer RNA for serine, MTTS1 [6]. 
 The molecular basis of a particular form of PPK, punctate PPK (OMIM 148600), is still 
unknown. Punctate PPK can be inherited as an autosomal dominant trait or it can present as an 
acquired disease. Both the inherited and the acquired forms have been associated with 
malignancies, such as Hodgkin's disease, renal, breast, pancreatic and colonic adenocarcinomas 
[2, 10]. The main clinical features include the presence of multiple small keratotic lesions on the 
palms and soles, with variable nail involvement [34, 35]. It is typical for these punctate lesions to 
coalesce on the soles, which are subject to continuous high pressure. The inherited form of 
punctate PPK shows age-dependent penetrance, with an estimated age of onset between 10 and 
33 years [1, 10, 35], and its molecular basis remains unknown. In a previous study, the keratin 
gene clusters on chromosomes 12 and 17 were excluded as the disease-causing genes [36]. 
In the present study we report the clinical and genetic findings in three pedigrees with the 
punctate form of PPK and the identification of the first locus for this phenotype, on chromosome 
15. The fact that there are no candidate known genes in this chromosomal location anticipates the 
discovery of a new gene with an important role in skin integrity. 
 
SUBJECTS AND METHODS 
We studied three different pedigrees with punctate PPK (fig 1). The first two families were a 
Jewish family originating from Syria (PPK1) and an Arab-Israeli family (PPK2). They 
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comprised 14 and 12 reported affected family members over four generations (fig 1). Thirteen 
and three affected individuals from pedigrees PPK1 and PPK2 available for this study, as well as 
unaffected individuals, were interviewed and examined by two physicians (A.Z. and L.H.). The 
third family, PPK3, originated from Mexico, with 30 reported affected individuals over four 
generations (fig 1). For this study, we had access to samples from nine affected family members. 
The clinical features of this pedigree have been reported previously [37]. 
 
Genomewide scan 
Blood samples from affected and unaffected family members were collected following informed 
consent and genomic DNA was extracted using the PureGene DNA Isolation Kit (Gentra 
Systems, Minneapolis, MN). A genomewide scan was performed on pedigree PPK1. Thirteen 
affected and 21 unaffected individuals were included in the study. The strategy for the 
genomewide scan has been described elsewhere [38-40]. Briefly, a panel of 324 microsatellite 
markers was used, with an average marker spacing of 10 cM and a semi-automated fluorescence-
based genotyping system. Most of the markers were chosen from version 8.0 of the Marshfield 
fluorescence-labeled genome screening set. 
Microsatellite markers used for the fine-mapping of the PPK locus on chromosome 15 
were chosen from the Marshfield genetic map [41] and PCR primer sequences were obtained 
from The Genome Database and the Cooperative Human Linkage Center. PCR products were 
resolved on 6% non-denaturing polyacrylamide gel electrophoresis and visualized by ethidium 
bromide staining. 
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Linkage analysis 
Prior to embarking on a genomewide scan, we performed a linkage power calculation on 
pedigree PPK1 using the SLINK software [42]. Power calculations were performed under the 
assumption of an autosomal dominant trait with age-dependent penetrance (age 0-10, 0.01; age 
11-15, 0.30; age 16-25, 0.80; age 26 or older, 0.96), 500 replications and a disease frequency of 
0.001. 
Two-point and multipoint LOD score analyses were performed for all markers genotyped 
in the genomewide scan. The linkage parameters used were the same as those described above 
for the linkage power calculations. LOD score values were calculated under two different 
scenarios in which unaffected individuals under age 20 and 35 were scored as unknown for 
linkage purposes. Two-point analyses were carried out using the MLINK program of the 
FASTLINK suite of programs [43-45]. Marker allele frequencies were estimated from the data 
obtained using observed and reconstructed genotypes of founders within the pedigrees. The 
alleles for all markers were re-coded using the RECODE program to avoid computational errors 
due to observed allele frequencies of 0.0 [46]. This re-coding program, which had no effect on 
any of the analyses, insured that alleles were numbered sequentially, and that every allelic 
frequency was non-zero. 
Multipoint analyses were performed using the SIMWALK program version 2.6 [47]. This 
software employs a Markov chain Monte Carlo approach, which allows for both a large number 
of founders in a pedigree and multiple markers in the computation of LOD scores. Markers were 
chosen for the multipoint analysis according to the following steps: i. all markers that showed 0.0 
recombination fractions with other markers according to the Marshfield genetic map [41] were 
put into distinct groups; ii. among markers within the distinct groups, those with the largest 
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heterozygosity values were chosen for multipoint analysis. This procedure was followed since 
the method used in SIMWALK has computational limitations for markers with 0.0 
recombination distances (E. Sobel, personal communication). The order and distance between 
the markers used in the multipoint analysis were deduced from the Marshfield genetic map [41]. 
Haplotypes for markers on chromosome 15 were reconstructed using the SIMWALK program 
[47], under the assumption of minimal recombination events. 
 
RESULTS 
The punctate PPK phenotype 
The age of onset of the disease in families PPK1 and PPK 2 (fig 1) ranged from 10 to 30 year-
old, although it was usually reported as later, since the lesions were mildly punctate and barely 
noticeable during the first years. Some of the lesions only became noticeable following water 
immersion. Keratotic lesions developed initially on the soles and within two to three years they 
progressed to involve the palms. Although the exact clinical involvement is sometimes difficult 
to document, since patients usually apply local treatments, there was a clear progression and 
worsening with time. The lesions became keratotic and increased in number during the early 
twenties and the involvement was very severe in older affected family members. The punctate 
component was more noticeable in the central part of the palms and soles, mainly on the palms, 
with 30 to over 100 lesions (fig 2A). On the soles, the clinical picture may be less specific, with 
large hyperkeratotic plaques in pressure areas (fig 2B), as seen with other keratodermas [48]. 
There was also involvement of the lateral aspect and the tips of some fingers, with small wart-
like hyperkeratotic lesions (fig 2C). There was no involvement of the dorsal aspects of the hands 
 8 
or legs, nor was there any involvement of the knees or elbows. Finally, there were no nail 
abnormalities. 
Previous groups had reported association of punctate PPK with different types of 
malignancy [2, 10]. However, we did not observe an increased prevalence of malignancy in 
either of these two families. The only case was that of an affected patient who died from breast 
cancer at age 94. 
 The clinical findings in family PPK3 have been reported previously [37]. Briefly, the 
proband (II:1) was an 83-year old male, presenting with multiple keratotic papules in his hands 
and feet, which progressed slowly. Histologically, the lesions displayed marked hyperkeratosis 
and hypergranulosis. As seen in pedigrees PPK1 and PPK2, he did not show any nail 
involvement. The proband died from pancreatic carcinoma and some of his siblings died from 
unknown types of cancer according to their relatives. 
 
Genetic mapping of the locus for punctate PPK on chromosome 15 
Linkage power calculations on pedigree PPK1 were performed to calculate the maximum 
theoretical LOD score in the pedigree and the probability to achieve a LOD score greater than 3. 
We obtained LOD score values of 5.73, 5.27 and 4.78 at recombination fraction of 0.00, 0.05 and 
0.1, respectively, and a probability of 89.4% for a LOD score greater than 3. 
Given these highly positive values, we proceeded with the genomewide scan in pedigree 
PPK1. Two genetic loci yielded an initial two-point LOD score greater than 1, corresponding to 
three adjacent microsatellite markers on chromosome 15, D15S1507 (Z=2.92), D15S653 
(Z=2.72) and D15S643 (Z=1.04), and one single marker on chromosome 21, D21S1437 
(Z=1.77). Multipoint analysis with markers in the region of chromosome 21 suggested that this 
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was a spurious positive LOD score. This result, together with the fact that the three markers on 
chromosome 15 were consecutive, pointed to this region as the more likely location for the PPK 
gene in this family. Interestingly, none of the chromosomal regions containing genes previously 
involved in phenotypes of abnormal keratinization achieved a promising positive LOD score in 
the genomewide scan. 
To confirm the identification of the locus for punctate PPK on chromosome 15, we 
genotyped 19 additional markers in the region. LOD score values were calculated under two 
different assumptions, scoring as unknown those unaffected individuals under age 20 and 35. 
Maximum two-point LOD scores of 4.70 (age 20 years) and 4.93 (age 35 years) were obtained 
for marker D15S988 at θ=0, confirming the initial results from the genomewide scan (table 1). A 
maximum multipoint LOD score of 5.22 supported the most likely location of the disease gene 
around marker D15S988. 
To determine the most likely critical linkage interval, we reconstructed the haplotypes for 
markers in the region. Two key recombination events (fig 3A) in individuals III:7 (centromeric), 
and II:13 and III:1 (telomeric) placed the disease locus to a 9.98-cM interval on 15q22-q24, 
flanked by markers D15S534 and D15S818. These observations were supported by additional 
recombination events observed in individuals II:2 and II:4. 
In an attempt to determine whether punctate PPK is a genetically heterogeneous 
phenotype, pedigrees PPK2 and PPK3 were also genotyped for markers on chromosome 15. 
Haplotype analyses were consistent with cosegregation of the disease phenotype in these two 
pedigrees and the locus on chromosome 15 identified in pedigree PPK1 (fig 3B, C). 
 
DISCUSSION 
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According to one of the more accurate clinical classifications proposed so far [1], there are seven 
different sub-types of punctate PPK, including four acquired and three inherited forms. Based on 
the characteristic features for each of them, we have classified the families reported in this study 
as type I punctate PPK or Buschke-Fischer-Brauer disease, with the keratoses distributed over 
the entire palmoplantar surfaces and coalescing into a more diffuse pattern over the pressure 
points of the sole. 
In the present study, we have identified the locus for type I punctate PPK on chromosome 
15q22-q24. The analysis of the disease-associated haplotype in pedigree PPK1 revealed the 
presence of three asymptomatic carriers, III:12, III:18 and IV:6 (fig 3A), ages 31, 20, and 14 
years at the time of the study, respectively. The most likely explanation for this is the 
characteristic age-dependent penetrance in this form of PPK, especially for III:18 and IV:6. In 
fact, previous reports on families with inherited punctate PPK gave an estimated age of onset 
between 10 and 33 year-old [1, 10, 35]. Moreover, IV:6 was suspected to present lesions on his 
palms after clinical evaluation, and previous to any genetic study. Two other unaffected 
individuals, II:13 and III:1, were shown to carry a partial disease-associated haplotype, 
representing recombination events (fig 3A). Although their ages, 53 and 45 years old, 
respectively, were above the age of onset in the family, ranging between 10 and 30 year-old, the 
possibility of reduced penetrance cannot be ruled out, and thus, these recombination events must 
be considered with caution. The analysis of markers within the identified critical linkage interval 
in pedigrees PPK2 and PPK3 also showed cosegregation with the disease phenotype (fig 3B, C), 
suggesting genetic homogeneity among the three punctate PPK families studied here. Since the 
number of available samples from these two pedigrees was small, the analysis of additional 
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family members, as well as new families with the same PPK phenotype will be necessary to 
evaluate the possibility of locus heterogeneity in punctate PPK. 
According to the physical maps at NCBI, UCSC (build #33), and deCODE Genetics [49], 
the critical linkage interval identified here corresponds to a region of 7.7 Mb (fig 4). Among both 
known and predicted genes, we identified one promising candidate, locus LOC123396, highly 
homologous to keratin 8. Considering the role of keratins in different forms of PPK [16-18, 20-
22], this novel gene appeared to be an excellent candidate for the punctate PPK phenotype 
studied here. The predicted gene encompasses a genomic region of 1398 bp, with 3 exons, 
supported by the alignment with 8 EST clones. The encoded predicted protein would be 403-
amino acids long, with high homology to different keratin proteins, such as keratin 8 (74% 
identity at the amino acid level); keratin 1 (51%), mutated in non-epidermolytic PPK [16]; 
keratins 6a and 6b (59%), mutated in pachyonychia congenita, a nail abnormality that presents 
with PPK [17, 18]; and keratin 5 (59%), mutated in epidermolysis bullosa simplex [50]. 
Sequencing of the genomic region containing locus LOC123396 in the three PPK pedigrees 
studied here, however, did not reveal any pathogenetic mutations. We detected two missense 
substitutions, A358T and R392C (accession # XP_063639), that were also present in control 
individuals. In addition, pairwise sequence alignment between LOC123396 and KRT8 suggested 
that LOC123396 could represent a processed pseudogene. In this regard, Hesse et al [51] have 
recently performed a thorough search for novel intermediate filament genes in the draft sequence 
of the human genome. As a result, they have described a "surprisingly high number of 
pseudogenes" related to KRT8 [51]. 
It is worth mentioning the presence of two additional positional candidate genes within 
the linkage interval, integrin alpha 11 (ITGA11) and lysyl oxidase-like 1 (LOXL1) genes. 
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Integrins constitute a family of proteins that mediate the interaction between different cell types 
and the extracellular matrix. ITGA11, in particular, has been hypothesized to play a role in areas 
of highly organized interstitial collagen networks [52], such as cartilage, intervertebral disc, and 
cornea organogenesis. Although there is no information on the expression of ITGA11 in skin, the 
proven role of adhesion molecules in PPK, such as desmosomal components [15], makes 
ITGA11 a candidate gene for the disease in our families. LOXL1, on the other hand, is a new 
member of the lysyl oxidase protein family of cross-linking enzymes for extracellular matrix 
proteins such as collagen and elastin. Human LOXL1 mRNA has been identified in a wide 
variety of tissues, but no information is available regarding its expression in skin. Mouse Loxl1 
protein, on the other hand, has been detected in mouse epidermis and hair follicle, as well as 
heart liver and kidney [53]. Finally, the syntenic region on mouse chromosome 9 does not harbor 
any candidate gene for the punctate PPK phenotype. 
In summary, we have identified a locus for punctate PPK, on chromosome 15q22-q24, 
which anticipates the identification of a novel gene involved in skin integrity. The study of 
multigenerational pedigrees with inherited diseases, such as the ones reported here, provides us 
with an excellent opportunity for the identification of new genes and pathways, and for the study 
of their function in both normal and diseased individuals. When these diseases are associated 
with a more systemic clinical picture, the identification of disease genes may give new insights 
into the etiology of other pathologies, such as the cardiomyopathy associated with PPK in Naxos 
disease. Moreover, as is the case for some skin disorders, such as Netherton syndrome and atopic 
dermatitis [54, 55], the knowledge gathered from rare Mendelian disorders such as PPK could 
derive important clues for more common complex traits characterized by abnormal 
keratinization, such as psoriasis [14]. 
 13 
Acknowledgments 
The authors wish to thank all family members for their invaluable contribution to this study, 
HaMut Lam and Sharona Tornovsky for expert technical assistance and Tanya Waran Lalin for 
her help in the final steps of this work. This study was supported by the Skin Disease Research 
Center, Department of Dermatology, Columbia University (P30 AR44535), research grants from 
the National Institutes of Health R01-AR44924 (to A.M.C.), K01-HG00055 (to D.G.), and 
MH59492 (to Jurg Ott, as mentor of D.L.), and by a grant from the Joint Research Fund of the 
Hebrew University and Hadassah, Jerusalem, Israel (to A. Z.). 
 14 
Electronic-Database Information: Center for Medical Genetics, Marshfield Medical Research 
Foundation, http://research.marshfieldclinic.org/genetics/. Cooperative Human Linkage Center 
(CHLC), http://lpg.nci.nih.gov/CHLC. The Genome Database (GDB), http://www.gdb.org. 
UCSC Human Genome Working Draft ("Golden Path"), http://genome.ucsc.edu/index.html. 
National Center for Biotechnology Information (NCBI), http://www.ncbi.nlm.nih.gov. Online 
Mendelian Inheritance in Man (OMIM), http://www.ncbi.nih.nlm.gov/Omim. 
 15 
REFERENCES 
 
1. Stevens HP, Kelsell DP, Bryant SP, Bishop DT, Spurr NK, Weissenbach J, Marger D, 
Marger RS, Leigh IM. Linkage of an American pedigree with palmoplantar keratoderma 
and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey 
and proposed updated classification of the keratodermas. Arch Dermatol 1996;132:640-
51. 
2. Stevens HP, Kelsell DP, Leigh IM, Ostlere LS, MacDermot KD, Rustin MH. Punctate 
palmoplantar keratoderma and malignancy in a four-generation family. Br J Dermatol 
1996;134:720-6. 
3. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, Otter 
MI, Murday VA, Mattu RK, McKenna WJ. Gene for arrhythmogenic right ventricular 
cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly 
hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58. 
4. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, Whittock 
N, Leigh IM, Stevens HP, Kelsell DP. Recessive mutation in desmoplakin disrupts 
desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, 
woolly hair and keratoderma. Hum Mol Genet 2000;9:2761-6. 
5. Djabali K, Martinez-Mir A, Horev L, Christiano AM, Zlotogorski A. Evidence for 
extensive locus heterogeneity in Naxos disease. J Invest Dermatol 2002;118:557-60. 
6. Sevior KB, Hatamochi A, Stewart IA, Bykhovskaya Y, Allen-Powell DR, Fischel-
Ghodsian N, Maw MA. Mitochondrial A7445G mutation in two pedigrees with 
palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179-85. 
 16 
7. Heathcote K, Syrris P, Carter ND, Patton MA. A connexin 26 mutation causes a 
syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). 
J Med Genet 2000;37:50-1. 
8. Howel-Evans W, McConnell RB, Clarke CA, Sheppard PM. Carcinoma of the 
oesophagus with keratosis palmaris et plantaris (tylosis): a study of two families. Quart J 
Med 1958;27:413-29. 
9. Huriez C, Deminatti M, Agache P, Mennecier M. [A gene dysplasia not previously 
known: frequently degenerative sclero-atrophying and keratodermic genodermatosis of 
the extremities]. Sem Hop 1968;44:481-8. 
10. Bennion SD, Patterson JW. Keratosis punctata palmaris et plantaris and adenocarcinoma 
of the colon. A possible familial association of punctate keratoderma and gastrointestinal 
malignancy. J Am Acad Dermatol 1984;10:587-91. 
11. Blanchet-Bardon C, Nazzaro V, Chevrant-Breton J, Espie M, Kerbrat P, Le Marec B. 
Hereditary epidermolytic palmoplantar keratoderma associated with breast and ovarian 
cancer in a large kindred. Br J Dermatol 1987;117:363-70. 
12. Torchard D, Blanchet-Bardon C, Serova O, Langbein L, Narod S, Janin N, Goguel AF, 
Bernheim A, Franke WW, Lenoir GM, Feunteun J. Epidermolytic palmoplantar 
keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian 
cancer. Nat Genet 1994;6:106-10. 
13. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode 
EL, Rowell SE, King MC. Novel inherited mutations and variable expressivity of 
BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. 
Am J Hum Genet 1995;57:1284-97. 
 17 
14. Kelsell DP, Stevens HP. The palmoplantar keratodermas: much more than palms and 
soles. Mol Med Today 1999;5:107-13. 
15. Kimyai-Asadi A, Kotcher LB, Jih MH. The molecular basis of hereditary palmoplantar 
keratodermas. J Am Acad Dermatol 2002;47:327-43. 
16. Kimonis V, DiGiovanna JJ, Yang JM, Doyle SZ, Bale SJ, Compton JG. A mutation in 
the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J 
Invest Dermatol 1994;103:764-9. 
17. Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ. Mutation of a 
type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995;10:363-5. 
18. Smith FJ, Jonkman MF, van Goor H, Coleman CM, Covello SP, Uitto J, McLean WH. 
A mutation in human keratin K6b produces a phenocopy of the K17 disorder 
pachyonychia congenita type 2. Hum Mol Genet 1998;7:1143-8. 
19. Reis A, Kuster W, Eckardt R, Sperling K. Mapping of a gene for epidermolytic 
palmoplantar keratoderma to the region of the acidic keratin gene cluster at 17q12-q21. 
Hum Genet 1992;90:113-6. 
20. Reis A, Hennies HC, Langbein L, Digweed M, Mischke D, Drechsler M, Schrock E, 
Royer-Pokora B, Franke WW, Sperling K, Kuster W. Keratin 9 gene mutations in 
epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 1994;6:174-9. 
21. McLean WH, Rugg EL, Lunny DP, Morley SM, Lane EB, Swensson O, Dopping-
Hepenstal PJ, Griffiths WA, Eady RA, Higgins C, Navsaria HA, Leigh IM, Strachan T, 
Kunkeler L, Munro CS. Keratin 16 and keratin 17 mutations cause pachyonychia 
congenita. Nat Genet 1995;9:273-8. 
 18 
22. Munro CS, Carter S, Bryce S, Hall M, Rees JL, Kunkeler L, Stephenson A, Strachan T. 
A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-
q21. J Med Genet 1994;31:675-8. 
23. Hennies HC, Kuster W, Mischke D, Reis A. Localization of a locus for the striated form 
of palmoplantar keratoderma to chromosome 18q near the desmosomal cadherin gene 
cluster. Hum Mol Genet 1995;4:1015-20. 
24. Armstrong DK, McKenna KE, Purkis PE, Green KJ, Eady RA, Leigh IM, Hughes AE. 
Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. 
Hum Mol Genet 1999;8:143-8. 
25. Whittock NV, Wan H, Morley SM, Garzon MC, Kristal L, Hyde P, McLean WH, 
Pulkkinen L, Uitto J, Christiano AM, Eady RA, McGrath JA. Compound heterozygosity 
for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly 
hair syndrome. J Invest Dermatol 2002;118:232-8. 
26. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, 
Norman M, Baboonian C, Jeffery S, McKenna WJ. Identification of a deletion in 
plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar 
keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24. 
27. Maestrini E, Korge BP, Ocana-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, 
Hovnanian A, Monaco AP, Munro CS. A missense mutation in connexin26, D66H, 
causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in 
three unrelated families. Hum Mol Genet 1999;8:1237-43. 
 19 
28. Kibar Z, Der Kaloustian VM, Brais B, Hani V, Fraser FC, Rouleau GA. The gene 
responsible for Clouston hidrotic ectodermal dysplasia maps to the pericentromeric 
region of chromosome 13q. Hum Mol Genet 1996;5:543-7. 
29. Lamartine J, Munhoz Essenfelder G, Kibar Z, Lanneluc I, Callouet E, Laoudj D, 
Lemaitre G, Hand C, Hayflick SJ, Zonana J, Antonarakis S, Radhakrishna U, Kelsell DP, 
Christianson AL, Pitaval A, Der Kaloustian V, Fraser C, Blanchet-Bardon C, Rouleau 
GA, G. W. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet 
2000;26:142-4. 
30. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, Jr., DiGiovanna JJ, 
Compton JG, Bale SJ. Mutations in the human connexin gene GJB3 cause 
erythrokeratodermia variabilis. Nat Genet 1998;20:366-9. 
31. Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, 
Weeks DE, Lathrop M, Uitto J, Christiano AM. A molecular defect in loricrin, the major 
component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 
1996;13:70-7. 
32. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan L, 
Roberts E, Woods CG, Markham A, Wong M, Widmer R, Ghaffar KA, Pemberton M, 
Hussein IR, Temtamy SA, Davies R, Read AP, Sloan P, Dixon MJ, Thakker NS. Loss-of-
function mutations in the cathepsin C gene result in periodontal disease and palmoplantar 
keratosis. Nat Genet 1999;23:421-4. 
33. Fischer J, Bouadjar B, Heilig R, Huber M, Lefevre C, Jobard F, Macari F, Bakija-
Konsuo A, Ait-Belkacem F, Weissenbach J, Lathrop M, Hohl D, Prud'homme JF. 
 20 
Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 
2001;10:875-80. 
34. Stanimirovic A, Kansky A, Basta-Juzbasic A, Skerlev M, Beck T. Hereditary 
palmoplantar keratoderma, type papulosa, in Croatia. J Am Acad Dermatol 1993;29:435-
7. 
35. Emmert S, Kuster W, Hennies HC, Zutt M, Haenssle H, Kretschmer L, Neumann C. 47 
patients in 14 families with the rare genodermatosis keratosis punctata palmoplantaris 
Buschke-Fischer-Brauer. Eur J Dermatol 2003;13:16-20. 
36. Kelsell DP, Stevens HP, Ratnavel R, Bryant SP, Bishop DT, Leigh IM, Spurr NK. 
Genetic linkage studies in non-epidermolytic palmoplantar keratoderma: evidence for 
heterogeneity. Hum Mol Genet 1995;4:1021-5. 
37. Davalos N, Ruiz M, Garcia-Vargas A, Davalos IP, Garcia-Cruz D, Figuera LE. Punctata 
Keratoderma and gastrointestinal malignancy in a Mexican Family. Am J Hum Genet 
2001;69:S287. 
38. Aita VM, Liu J, Knowles JA, Terwilliger JD, Baltazar R, Grunn A, Loth JE, Kanyas K, 
Lerer B, Endicott J, Wang Z, Penchaszadeh G, Gilliam TC, Baron M. A comprehensive 
linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar 
affective disorder locus. Am J Hum Genet 1999;64:210-7. 
39. Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, Lord C, Iversen P, 
Hoh J, Ott J, Gilliam TC. A genomewide screen for autism susceptibility loci. Am J Hum 
Genet 2001;69:327-40. 
 21 
40. Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A, Brito M, Green P, 
Mustalahti K, Maki M, Gilliam TC, Partanen J. Genomewide linkage analysis of celiac 
disease in Finnish families. Am J Hum Genet 2002;70:51-9. 
41. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human 
genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 
1998;63:861-9. 
42. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci USA 
1989;86:4175-8. 
43. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in 
humans. Proc Natl Acad Sci USA 1984;81:3443-6. 
44. Cottingham RW, Jr., Idury RM, Schaffer AA. Faster sequential genetic linkage 
computations. Am J Hum Genet 1993;53:252-63. 
45. Schaffer AA, Gupta SK, Shriram K, Cottingham RW, Jr. Avoiding recomputation in 
linkage analysis. Hum Hered 1994;44:225-37. 
46. Weeks DE. RECODE- a program for recoding base-pair sized alleles into integer- 
numbered alleles. ftp://watson.hgen.edu/pub/recode.tar.Z 2000. 
47. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, 
location scores, and marker-sharing statistics. Am J Hum Genet 1996;58:1323-37. 
48. Kljuic A, Gilead L, Martinez-Mir A, Frank J, Christiano AM, Zlotogorski A. A nonsense 
mutation in the desmoglein 1 gene underlies striate keratoderma. Exp Dermatol (in 
press). 
49. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, 
Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, 
 22 
Thorgeirsson TE, Gulcher JR, Stefansson K. A high-resolution recombination map of the 
human genome. Nat Genet 2002;31:241-7. 
50. Lane EB, Rugg EL, Navsaria H, Leigh IM, Heagerty AH, Ishida-Yamamoto A, Eady 
RA. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin 
blistering. Nature 1992;356:244-6. 
51. Hesse M, Magin TM, Weber K. Genes for intermediate filament proteins and the draft 
sequence of the human genome: novel keratin genes and a surprisingly high number of 
pseudogenes related to keratin genes 8 and 18. J Cell Sci 2001;114:2569-75. 
52. Tiger CF, Fougerousse F, Grundstrom G, Velling T, Gullberg D. alpha11beta1 integrin 
is a receptor for interstitial collagens involved in cell migration and collagen 
reorganization on mesenchymal nonmuscle cells. Dev Biol 2001;237:116-29. 
53. Molnar J, Fong KS, He QP, Hayashi K, Kim Y, Fong SF, Fogelgren B, Szauter KM, 
Mink M, Csiszar K. Structural and functional diversity of lysyl oxidase and the LOX-like 
proteins. Biochim Biophys Acta 2003;1647:220-4. 
54. Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, 
Abecasis GR, Jones EY, Harper JI, Hovnanian A, Cookson WO. Gene polymorphism in 
Netherton and common atopic disease. Nat Genet 2001;29:175-8. 
55. Norgett EE, Kelsell DP. SPINK5: both rare and common skin disease. Trends Mol 
Med 2002;8:7. 
 23 
 Figure Legends 
 
Figure 1 Pedigrees of families with punctate PPK. Affected and unaffected individuals, and 
those of unknown phenotype are denoted by black, empty and gray symbols, respectively. Most 
of the alive individuals from family PPK1 were available for this study. Available DNA samples 
from families PPK2 and PPK3 are indicated by an asterisk.  
 
Figure 2 Clinical presentation of the PPK phenotype. (A) Palmar punctate lesions (PPK1); 
(B) Plantar keratoderma involving pressure areas of heels, proximal soles and the big toes 
(PPK2); (C) Involvement of the lateral aspects and tip of fingers (PPK2). 
 
Figure 3 Simplified pedigrees for families PPK1, PPK2 and PPK3 showing the haplotypes 
for markers on chromosome 15q22-q24. The age at the time of the study is shown and markers 
analyzed are indicated in each panel. The disease associated-chromosome is shaded. Key 
recombination events (II:13, III:1 and III:7 in PPK1) are indicated by arrows. A question mark 
indicates the genotype was not available. 
 
Figure 4 Schematic representation of chromosome 15 showing the position of markers 
used in this study and the linkage intervals identified. Markers defining the locus for punctate 
PPK are indicated in boldface. The critical linkage interval defined by recombination events in 
affected individuals only (dark bar), and affected and unaffected individuals over the age of 40 
(light bar) are indicated. Genetic distances (cM) are based on the maps at Marshfield [41] and 
 24 
deCODE Genetics [49]; physical positions (Mb) have been obtained from NCBI, UCSC (build 
#33), and the integrated map at deCODE genetics [49]. 
 25 
Table 1 Two-point LOD Scores for Markers on 15q22-q24 in pedigree PPK1 
LOD SCOREa AT θ  = MARKER POSITION (cM) 0 .01 .05 .1 .2 .3 .4 
D15S643 52.33 -0.14 0.75 1.40 1.56 1.39 0.94 0.35 
D15S1036 57.37 -0.45 0.53 1.30 1.51 1.37 0.93 0.33 
D15S1507 60.17 -0.15 0.81 1.56 1.74 1.56 1.06 0.40 
D15S1009 61.28 -0.74 0.25 1.04 1.27 1.19 0.80 0.27 
D15S651 61.84 -1.22 -0.23 0.56 0.80 0.74 0.44 0.11 
D15S534 61.84 2.17 2.28 2.40 2.30 1.85 1.20 0.43 
D15S125 64.20 2.08 2.04 1.86 1.63 1.15 0.65 0.20 
D15S988 66.90 4.93 4.84 4.51 4.08 3.13 2.06 0.86 
D15S1000 67.85 1.04 1.02 0.92 0.78 0.51 0.25 0.06 
D15S650 70.73 4.33 4.26 3.97 3.59 2.76 1.80 0.72 
D15S818 71.82 2.36 2.38 2.35 2.17 1.64 0.97 0.32 
D15S653 78.92 1.85 1.97 2.18 2.19 1.85 1.25 0.49 
D15S655 82.84 -0.49 -0.34 0.02 0.21 0.29 0.21 0.09 
a Unaffected individuals under the age of 35 years were scored as unknown for linkage purposes. 
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